Baylor Scott & White Health gastroenterology treats patients with gastrointestinal and liver diseases in regionally and nationally recognized centers of excellence, referral centers, local endoscopy centers and physician offices across Central and North Texas.
Your patients will have access to renowned digestive health experts, advanced diagnostic and treatment facilities, and innovative clinical research the goal of finding the best ways to address digestive disorders, including:
- Diarrheal diseases, including Clostridium difficile (C. diff)
- Esophageal diseases and disorders
- Gastrointestinal motility disorders
- Inflammatory bowel diseases
- Liver diseases
- Pancreatic diseases
- Hepatitis C
Treating IBD in 2018 – How Close Are We to the Promise of Personalized Medicine?
On April 14, join us for the third annual IBD Center Conference at Baylor Charles A. Sammons Cancer Center at Baylor University Medical Center, part of Baylor Scott & White Health. Learn more here.
Tremendous progress has occurred in our understanding of IBD mechanisms. In the future, the selection of treatment will be personalized, i.e. will be based on the genetic composition, microbiomic profile and immunologic phenotype of the patient.
This CME course will review the current state and future outlook for mechanism-based therapies. The course will also address other aspects of individualized management, including smoking cessation, transition from pediatric to adult IBD care, psychiatric treatment and management of dermatologic disease.